Structure-Activity Relationship of Biakamide, Selective Growth Inhibitors under Nutrient-Starved Condition from

Ryosuke Ishida1, Hirokazu Matsumoto1, Sayaka Ichii1

  • 1Graduate School of Pharmaceutical Sciences, Osaka University.

Insights

Marine sponge compounds, biakamides, show potential as anticancer drugs by inhibiting cancer cell growth under nutrient-deficient conditions. A simplified analog retains significant activity, aiding drug development.

Area of Science:

  • Marine Natural Products Chemistry
  • Medicinal Chemistry
  • Cancer Biology

Background:

  • The tumor microenvironment, often characterized by nutrient deficiency, presents a critical target for anticancer drug discovery.
  • Biakamides A-D, isolated from the marine sponge Petrosaspongia sp., exhibit growth inhibitory effects on cancer cells adapted to glucose-deprived conditions.
  • These compounds offer potential as novel therapeutic agents and tools for understanding cancer cell adaptation mechanisms.

Purpose of the Study:

  • To investigate the structure-activity relationship (SAR) of biakamides to develop easily accessible analogs.
  • To gain insights into the contribution of specific substructures to the growth-inhibitory activity of biakamides.
  • To facilitate the development of novel anticancer drugs targeting nutrient-deficient tumor microenvironments.

Main Methods:

  • Isolation and characterization of biakamides A-D from Petrosaspongia sp.
  • Evaluation of growth inhibitory activity against cancer cells under glucose-deprived conditions.
  • Systematic structural modification and SAR analysis of biakamide analogs.

Main Results:

  • 14,15-dinor-biakamide C, an easily synthesized analog, demonstrated comparable activity to the natural biakamide C.
  • The terminal acyl chain was identified as crucial for target molecule interaction.
  • The amide moiety, including the thiazole ring, showed structural flexibility without compromising activity.

Conclusions:

  • Simplified biakamide analogs can be developed for anticancer drug discovery.
  • The terminal acyl chain and the amide-thiazole core are key structural features for maintaining growth-inhibitory activity.
  • This research provides a foundation for designing potent and accessible anticancer agents targeting the tumor microenvironment.

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.8K
Relationship Growth01:27

Relationship Growth

Interpersonal relationships progress through stages, beginning with awareness and moving toward mutuality, where emotional connections deepen. While many relationships remain at moderate levels of mutuality, deeper connections form through self-disclosure, trust, and interdependence.Self-DisclosureSelf-disclosure involves revealing personal information, starting with surface-level details and gradually progressing to more intimate content. As trust grows, individuals feel more comfortable...
220
Local Anesthetics: Chemistry and Structure-Activity Relationship01:30

Local Anesthetics: Chemistry and Structure-Activity Relationship

Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
6.7K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.8K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.9K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
979